Chris LaVictoire Mahai, Director at abrdn Life Sciences Investors, bought HQL on Jul 16, 2026
Data as of Oct 16
- Traded
- Jul 16, 2026
- Disclosed
- Jul 20, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
HQL since disclosure
−14.1%
Similar stocks (XLF) since disclosure
−0.9%
XLF — its sector index fund
Change in closing price from Jul 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.